Pulmonx (LUNG) Cash from Investing Activities (2019 - 2025)
Pulmonx (LUNG) reported Cash from Investing Activities of $8.7 million for Q3 2025, up 29.03% year-over-year from $6.8 million in Q3 2024, and up 59.22% on a QoQ basis from $5.5 million in Q2 2025.
Pulmonx (LUNG) has 7 years of Cash from Investing Activities data on file, last reported at $8.7 million in Q3 2025.
- Quarterly Cash from Investing Activities rose 29.03% year-over-year to $8.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $44.6 million (up 6713.76% YoY) and the FY2024 annual result came in at $17.5 million, up 970.75% from the prior year.
- Cash from Investing Activities improved to $8.7 million in Q3 2025 per LUNG's latest filing, from $5.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $16.3 million in Q1 2025 and bottomed at -$29.1 million in Q4 2021.
- The 5-year median for Cash from Investing Activities is -$727000.0 (2022), against an average of -$237684.2.
- The widest annual swing landed in 2021, when Cash from Investing Activities sank 4392.11%; it then jumped 2143.18% in 2023.
- Tracing LUNG's Cash from Investing Activities over 5 years: stood at -$29.1 million in 2021, then surged by 97.5% to -$727000.0 in 2022, then slumped by 278.95% to -$2.8 million in 2023, then jumped by 610.6% to $14.1 million in 2024, then tumbled by 38.07% to $8.7 million in 2025.
- Per Business Quant, the three latest LUNG Cash from Investing Activities figures stand at $8.7 million (Q3 2025), $5.5 million (Q2 2025), and $16.3 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8.71 Mn |
| Sep 30, 2025 | 8.71 Mn |
| Jun 30, 2025 | 5.47 Mn |
| Jun 30, 2025 | 5.47 Mn |
| Mar 31, 2025 | 16.31 Mn |
| Mar 31, 2025 | 16.31 Mn |
| Dec 31, 2024 | 14.07 Mn |
| Dec 31, 2024 | 14.07 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | -835,000.00 |
| Jun 30, 2024 | -835,000.00 |
| Mar 31, 2024 | -2.51 Mn |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | -2.76 Mn |
| Dec 31, 2023 | -2.76 Mn |
| Sep 30, 2023 | 987,000.00 |
| Sep 30, 2023 | 987,000.00 |
| Jun 30, 2023 | -813,000.00 |
| Jun 30, 2023 | -813,000.00 |
| Mar 31, 2023 | 574,000.00 |
| Mar 31, 2023 | 574,000.00 |
| Dec 31, 2022 | -727,000.00 |
| Dec 31, 2022 | -727,000.00 |
| Sep 30, 2022 | 44,000.00 |
| Sep 30, 2022 | 44,000.00 |
| Jun 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | -5.62 Mn |
| Mar 31, 2022 | -5.62 Mn |
| Dec 31, 2021 | -29.12 Mn |
| Dec 31, 2021 | -29.12 Mn |
| Sep 30, 2021 | -3.41 Mn |
| Sep 30, 2021 | -3.41 Mn |
| Jun 30, 2021 | -1.19 Mn |
| Jun 30, 2021 | -1.19 Mn |
| Mar 31, 2021 | -12.53 Mn |
| Mar 31, 2021 | -12.53 Mn |
| Dec 31, 2020 | -693,000.00 |
| Dec 31, 2020 | -693,000.00 |
| Sep 30, 2020 | -76,000.00 |
| Sep 30, 2020 | -76,000.00 |
| Jun 30, 2020 | 3.44 Mn |
| Jun 30, 2020 | 3.44 Mn |
| Mar 31, 2020 | 10.02 Mn |
| Mar 31, 2020 | 10.02 Mn |
| Dec 31, 2019 | 3.03 Mn |
| Dec 31, 2019 | 3.03 Mn |